Of the more than 20 million new cancer cases diagnosed globally in 2022, nearly half occurred in Asia—where an even higher majority of the 9.7 million deaths were also reported, according to the International Agency for Research on Cancer and American Cancer Society’s April 2024 estimates. And although “the cancer mortality burden in the African and Asian regions is disproportionately greater than the corresponding incidence burden,” the authors wrote, “Europe [also] has a disproportionately higher cancer incidence and mortality burden, given that the continent has one-fifth of the global cancer cases and cancer deaths yet less than 10% of the global population.”